Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial - Kahatano, Aina-ekisha; Mpina, Maxmillian Gideon; Vanobberghen, Fiona; Hassan, Omary; Urasa, Nsiande; Sasamalo, Ibrahim; Mswata, Sarah; Paris, Daniel; Gajewski, Suzanne; Saxena, Meera; Fürle, Kristin; Kiehl, Viktoria; et al. (EClinicalMedicine, 2025)
Gesehen am 17.02.2026